1. Beierwaltes WH, Robbins J. Familial increase in the thyroxine-binding sites in serum alpha globulin. J. Clin. Invest. 38: 1683-1688, 1959.

2. Hayashi Y, Refetoff S. Genetic abnormalities of thyroid hormone transport serum proteins. In: Molecular endocrinology: Basic concepts and clinical correlations., edited by B. Weintraub. New York: Raven Press, 1995, p. 371-387.

3. Sunthornthepvarakul T, Likitmaskul S, Ngowngarmratana S, Angsusingha K, Sureerat K, Scherberg NH, Refetoff S. Familial dysalbuminemic hypertriiodothyroninemia: a new dominantly inherited albumin defect. J. Clin. Endocrinol. Metab. 83: 1448-1454, 1998.

4. Refetoff S. Inherited thyroxine-binding globulin (TBG) abnormalities in man. Endocr. Rev. 10: 275-293, 1989.

5. Refetoff S, Robin NI, Alper CA. Study of four new kindreds with inherited thyroxine-binding globulin abnormalities: Possible mutations of a single gene locus. J Clin Invest 51: 848-867, 1972.

6. Burr WA, Ramsden DB, Hoffenberg R. Hereditary abnormalities of thyroxine-binding globulin concentration. Quart. J. Med. 49: 295-313, 1980.

7. Trent JM, Flink IL, Morkin E, Van Tuinen P, Ledbetter DH. Localization of the human thyroxine-binding globulin gene to the long arm of the X chromosome (Xq21-22). Am. J. Hum. Genet. 41: 428-435, 1987.

8. Mori Y, Miura Y, Oiso Y, Seo H, Takazumi K. Precise localization of the human thyroxine-binding globulin gene to chromosome Xq22.2 by fluorescence in situ hybridization. Hum. Genet. 96: 481-482, 1995.

9. Wada N, H. C, Shimizu C, Kijima H, Kubo M, Koike T. A novel misssense mutation in codon 218 of the albumin gene in a distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J. Clin. Endocriol. Metab. 82: 3246-3250, 1997.

10. Pannain S, Feldman M, Eiholzer U, Weiss RE, Scherberg NH, Refetoff S. Familial dysalbuminemic hyperthyroxinemia in a Swiss family caused by a mutant albumin (R218P) shows an apparent discrepancy between serum concentration and affinity for thyroxine. J. Clin. Endocrinol. Metab. 85: 2786-2792, 2000.

11. Okamoto H, Mori Y, Tani Y, Nakagomi Y, Sano T, Ohyama K, Saito H, Oiso Y. Molecular analysis of females manifesting thyroxine-binding globulin (TBG) deficiency: selective X-chromosome inactivation responsible for the difference between phenotype and genotype in TBG-deficient females. J. Clin. Endocrinol. Metab. 81: 2204-2208, 1996.

12. Refetoff S, Selenkow HA. Familial thyroxine-binding globulin deficiency in a patient with Turner's syndrome (X0): Genetic study of a kindred. N. Engl. J. Med. 278: 1081-1087, 1968.

13. Reutrakul S, Janssen OE, Refetoff S. Three novel mutations causing complete T₄-binding globulin deficiency. J. Clin. Endocrinol. Metab. 86: 5039-5044, 2001.

14. Mannavola D, Vannucchi G, Fugazzola L, Cirello V, Campi I, Radetti G, Persani L, Refetoff S, Beck-Peccoz P. TGB Deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature. J Mol Med 84: 864-871, 2006.

15. Domingues R, Bugalho MJ, Garrão A, Boavida JM, Sobrinho L. Two novel variants in thyroxine-binding globulin (TBG) gene behind the diagnosis of TBG deficiency. Eur. J. Endocrinol. 146: 485-490, 2002.

16. Ueta Y, Mitani Y, Yoshida A, Taniguchi S, Mori A, Hattori K, Hisatome I, Manabe I, Takeda K, Sato R, Ahmmed GU, Tsuboi M, Ohtahara A, Hiroe K, Tanaka Y, Shigemasa C. A novel mutation causing complete deficiency of thyroxine binding globulin. Clin. Endocrinol. 47: 1-5, 1997.

17. Hershkovitz E, Leiberman E, Refetoff S, Pilpell D, Phillip M. High prevalence of thyroxine-binding globulin deficiency among Bedouin infants in southern Israel. Isr. J. Med. Sci. 31: 500-502, 1995.

18. Miura Y, Hershkovitz E, Inagaki A, Parvari R, Oiso Y, Phillip M. A novel mutation causing complete thyroxine-binding globulin deficiency (TBG-CD-Negev) among the Bedouins in southern Israel. J. Clin. Endocrinol. Metab. 85: 3687-3689, 2000.

19. Su CC, Wu YC, Chiu CY, Won JG, Jap TS. Two novel mutations in the gene encoding thyroxine-binding globulin (TBG) as a cause of complete TBG deficiency in Taiwan. Clin. Endocrinol. (Oxf) 58: 409-414, 2003.

20. Li P, Janssen OE, Takeda K, Bertenshaw RH, Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency caused by a single nucleotide deletion in the TBG gene. Metabolism 40: 1231-1234, 1991.

21. Carvalho GA, Weiss RE, Refetoff S. Complete Thyroxine-binding Globulin (TBG) deficiency produced by a mutation in the acceptor splice site causing frameshift and early termination of translation (TBG-Kankakee). J. Clin. Endocrinol. Metab. 83: 3604-3608, 1998.

22. Mori Y, Takeda K, Charbonneau M, Refetoff S. Replacement of Leu227 by Pro in thyroxine-binding globulin (TBG) is associated with complete TBG deficiency in three of eight families with this inherited defect. J. Clin. Endocrinol. Metab. 70: 804-809, 1990.

23. Carvalho GA, Weiss RE, Vladutiu AO, Refetoff S. Complete deficiency of thyroxine-binding globulin (TBG-CD Buffalo) caused by a new nonsense mutation in the thyroxine-binding globulin gene. Thyroid 8: 161-165, 1998.

24. Reutrakul S, Dumitrescu A, Macchia P, Moll GWJ, Vierhapper H, Refetoff S. Complete thyroxine-binding globulin (TBG) deficiency in two families without mutations in coding or promoter regions of the TBG gene: in vitro demonstration of exon skipping. J. Clin. Endocrinol. Metab. 87: 1045-1051, 2002.

25. Yamamori I, Mori Y, Seo H, Hirooka Y, Imamura S, Miura Y, Matsui N, Oiso Y. Nucleotide deletion resulting in frameshift as a possible cause of complete thyroxine-binding globulin deficiency in six Japanese families. J. Clin. Endocrinol. Metab. 73: 262-267, 1991.

26. Yamamori I, Mori Y, Miura Y, Tani Y, Imamura S, Oiso Y, Seo H. Gene screening of 23 Japanese families with complete thyroxine-binding globulin deficiency: Identification of a nucleotide deletion at codon 352 as a common cause. Endocr. J. 40: 563-569, 1993.

27. Moeller LC, Fingerhut A, Lahner H, Grasberger H, Weimer B, Happ J, Mann K, Janssen OE. C-Terminal Amino Acid Alteration rather than Late Termination Causes Complete Deficiency of Thyroxine-Binding Globulin CD-NeuIsenburg. J Clin Endocrinol Metab 91: 3215-3218, 2006.

28. Fingerhut A, Reutrakul S, Knuedeler SD, Moeller LC, Greenlee C, Refetoff S, Janssen OE. Partial deficiency of thyroxine-binding globulin-allentown is due to a mutation in the signal Peptide. J Clin Endocrinol Metab 89: 2477-2483, 2004.

29. Sarne DH, Refetoff S, Nelson JC, Dussault J. A new inherited abnormality of thyroxine-binding globulin (TBG-San Diego) with decreased affinity for thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab. 68: 114-119, 1989.

30. Bertenshaw R, Sarne D, Tornari J, Weinberg M, Refetoff S. Sequencing of the variant thyroxine-binding globulin (TBG)-San Diego reveals two nucleotide substitutions. Biochim. Biophys. Acta 1139: 307-310, 1992.

31. Janssen OE, Astner ST, Grasberger H, Gunn SK, Refetoff S. Identification of thyroxine-binding globulin-San Diego in a family from Houston and its characterization by in vitro expression using Xenopus oocytes. J. Clin. Endocrinol. Metab. 85: 368-372, 2000.

32. Mori Y, Seino S, Takeda K, Flink IL, Murata Y, Bell GI, Refetoff S. A mutation causing reduced biological activity and stability of thyroxine-binding globulin probably as a result of abnormal glycosylation of the molecule. Mol. Endocrinol. 3: 575-579, 1989.

33. Takamatsu J, Refetoff S, Charbonneau M, Dussault JH. Two new inherited defects of the thyroxine-binding globulin (TBG) molecule presenting as partial TBG deficiency. J. Clin. Invest. 79: 833-840, 1987.

34. Janssen OE, Refetoff S. In-vitro expression of thyroxine-binding globulin (TBG) variants: Impaired secretion of TBGPRO-227 but not TBGPRO-113. J. Biol. Chem. 267: 13998-14004, 1992.

35. Refetoff S, Murata Y. X-chromosome-linked inheritance of the variant thyroxine-binding globulin in serum of Australian Aborigines: Its physical, chemical and biological properties. J Clin Endocrinol Metab 60: 356-360, 1985.

36. Takeda K, Mori Y, Sobieszczyk S, Seo H, Dick M, Watson F, Flink IL, Seino S, Bell GI, Refetoff S. Sequence of the variant thyroxine-binding globulin of Australian Aborigines: Only one of two amino acid replacements is responsible for its altered properties. J. Clin. Invest. 83: 1344-1348, 1989.

37. Bertenshaw R, Takeda K, Refetoff S. Sequencing of the variant thyroxine-binding globulin (TBG)-Quebec reveals two nucleotide substitutions. Am. J. Hum. Genet. 48: 741-744, 1991.

38. Miura Y, Mori Y, Yamamori I, Tani Y, Murata Y, Yoshimoto M, Kinoshita E, Matsumoto T, Oiso Y, Seo H. Sequence of a variant thyroxine-binding globulin (TBG) in a family with partial TBG deficiency in Japanese (TBG-PDJ). Endocr. J. 40: 127-132, 1993.

39. Miura Y, Mori Y, Kambe F, Tani Y, Oiso Y, Seo H. Impaired intracellular transport contributes to partial thyroxine-binding globulin (TBG) deficiency in a Japanese family. J. Clin. Endocrinol. Metab. 79: 740-744, 1994.

40. Takeda K, Iyota K, Mori Y, Tamura Y, Suehiro T, Kubo Y, Refetoff S, Hashimoto K. Gene screening in Japanese families with complete deficiency of thyroxine-binding globulin demonstrates that a nucleotide deletion at codon 352 may be a race specific mutation. Clin. Endocrinol. 40: 221-226, 1994.

41. Daiger SP, Rummel DP, Wang L, Cavalli-Sforza LL. Detection of genetic variation with radioactive ligands. IV. X-linked, polymorphic genetic variation of thyroxin-binding globulin (TBG). Am. J. Hum. Genet. 33: 640-648, 1981.

42. Takamatsu J, Ando M, Weinberg M, Refetoff S. Isoelectric focusing variant thyroxine-binding globulin (TBG-S) in American Blacks: Increased heat lability and reduced concentration in serum. J. Clin. Endocrinol. Metab. 63: 80-87, 1986.

43. Waltz MR, Pullman TN, Takeda K, Sobieszczyk P, Refetoff S. Molecular basis for the properties of the thyroxine-binding globulin-slow variant in American Blacks. J. Endocrinol. Invest. 13: 343-349, 1990.

44. Takamatsu J, Refetoff S. Inherited heat stable variant thyroxine-binding globulin (TBG-Chicago). J. Clin. Endocrinol. Metab. 63: 1140-1144, 1986.

45. Janssen EO, Chen B, Büttner C, Refetoff S, Scriba PC. Molecular and structural characterization of the heat-resistant thyroxine-binding globulin-Chicago. J. Biol. Chem. 270: 28234-28238, 1995.

46. Murata Y, Takamatsu J, Refetoff S. Inherited abnormality of thyroxine-binding globulin with no demonstrable thyroxine-binding activity and high serum levels of denatured thyroxine-binding globulin. N. Engl. J. Med. 314: 694-699, 1986.

47. Sarne DH, Refetoff S, Murata Y, Dick M, Watson F. Variant thyroxine-binding globulin in serum of Australian Aborigines. A comparison with familial TBG deficiency in Caucasians and American Blacks. J. Endocrinol. Invest. 8: 217-224, 1985.

48. Kobayashi H, Sakurai A, Katai M, Hashizume K. Autosomally transmited low concentration of thyroxine-binding globuline. Thyroid 9: 159-163, 1999.

49. Griffiths KD, Virdi NK, Rayner PHW, Green A. Neonatal screening for congenital hypothyroidism by measurement of plasma thyroxine and thyroid stimulating hormone concentrations. Brit. Med. J. 291: 117-120, 1985.

50. Brown SK, Bellisario R. Measurement of thyroxine-binding globulin (TBG) levels from dried blood spot specimens: Detection of TBG deficiency and TBG excess in infants. In: Genetic Disease: Screening and Management, edited by T. P. Carter andA. H. Wiley Alan R. Liss, Inc., 1986, p. 373-384.

51. Refetoff S, Charbonneau M, Sarne DH, Takamatsu J, Dussault JH. Resistance to thyroid hormones and screening for high thyroxine at birth. In: Research for Congenital Hypothyroidism. Plenum Publishing Corp., 1989, p. 165-172.

52. Hayashi Y, Mori Y, Janssen OE, Sunthornthepvarakul T, Weiss RE, Takeda K, Weinberg M, Seo H, Bell GI, Refetoff S. Human thyroxine-binding globulin gene: Complete sequence and transcriptional regulation. Mol. Endocrinol. 7: 1049-1060, 1993.

53. Mori Y, Miura Y, Takeuchi H, Igarashi Y, Sugiura J, Oiso Y. Gene amplification as a cause for inherited thyroxine-binding globulin excess in two Japanese families. J. Clin. Endocrinol. Metab. 80: 3758-3762, 1995.

54. Kamboh MI, Ferrell RE. A sensitive immunoblotting technique to identify thyroxine-binding globulin protein heterogeneity after isoelectric focusing. Biochem. Genet. 24: 273-280, 1986.

55. Constans J, Ribouchon MT, Gouaillard C, Chaventré A, Clayton J. A new polymorphism of thyroxin-binding globulin in three African groups (Mali) with endemic nodular goitre. Hum. Genet. 89: 199-203, 1992.

56. Kambe F, Seo H, Mori Y, Murata Y, Janssen OE, Refetoff S, Matsui N. An additional carbohydrate chain in the variant thyroxine-binding globulin-Gary (TBGAsn-96) impairs its secretion. Mol. Endocrinol. 6: 443-449, 1992.

57. Miura Y, Kambe F, Yamamori I, Mori Y, Tani Y, Murata Y, Oiso Y, Seo H. A truncated thyroxine-binding globulin due to a frameshift mutation is retained within the rough endoplasmic reticulum: A possible mechanism of complete thyroxine-binding globulin deficiency in Japanese. J. Clin. Endocrinol. Metab. 78: 283-287, 1994.

58. Zhou A, Wei Z, Read RJ, Carrell RW. Structural mechanism for the carriage and release of thyroxine in the blood. Proc Natl Acad Sci U S A 103: 13321-13326, 2006.

59. Benson MD. Amyloidosis (Chapter131). In: The Metabolic and Molecular Basis of Inherited Disease., edited by C. R. Scriver, A. L. Beaudet, W. S. Sly andD. Valle. New York: McGraw Hill Inc., 1995.

60. Refetoff S, Dwulet FE, Benson MD. Reduced affinity for thyroxine in two of three structural thyroxine-binding prealbumin variants associated with familial amyloidotic polyneuropathy. J. Clin. Endocrinol. Metab. 63: 1432-1437, 1986.

61. Rosen HN, Moses AC, Murrell JR, Liepnieks JJ, Benson MD. Thyroxine interactions with transthyretin: a comparison of 10 naturally occurring human transthyretin variants. J. Clin. Endocrinol. Metab. 77: 370-374, 1993.

62. Lalloz MR, Byfield PG, Goel KM, Loudon MM, Thomson JA, Himsworth RL. Hyperthyroxinemia due to the coexistence of two raised affinity thyroxine-binding proteins (albumin and prealbumin) in one family. J Clin Endocrinol Metab 64: 346-352, 1987.

63. Akbari MT, Fitch NJ, Farmer M, Docherty K, Sheppard MC, Ramsden DB. Thyroxine-binding prealbumin gene: a population study. Clin. Endocrinol. 33: 155-160, 1990.

64. Fitch NJS, Akbary MT, Ramsden DB. An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J. Endocrinol. 129: 309-313, 1991.

65. Moses C, Rosen HN, Moller DE, Tsuzaki S, Haddow JE, Lawlor J, Liepnieks JJ, Nichols WC, Benson MD. A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia. J. Clin. Invest. 86: 2025-2033, 1990.

66. Rosen HN, Murrell JR, Liepnieks JL, Benson MD, Cody V, Moses AC. Threonine for alanine substitution at position 109 of transthyretin differentially alters human transthyretin's affinity for iodothyronines. J. Clin. Endocrinol. Metab. 134: 27-34, 1994.

67. Refetoff S, Marinov VSZ, Tunca H, Byrne MM, Sunthornthepvarakul T, Weiss RE. A new family with hyperthyroxinemia due to transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 81: 3335-3340, 1996.

68. Harrison HH, Gordon ED, Nichols WC, Benson MD. Biochemical and clinical characterization of prealbuminCHICAGO:An apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis. Am. J. Med. Gen. 39: 442-452, 1991.

69. Scrimshaw BJ, Fellowes AP, Palmer BN, Croxson MS, Stockigt JR, George PM. A novel variant of transthyretin (prealbumin), Thr119 to Met, associated with increased thyroxine binding. Thyroid 2: 21-26, 1992.

70. Alves IL, Divino CM, Schussler GC, Altland K, Almeida MR, Palha JA, Coelho T, Costa PP, Saraiva MJM. Thyroxine binding in a TTR met 119 kindred. J. Clin. Endocrinol. Metab. 76: 484-488, 1993.

71. Curtis AL, Scrimshaw BL, Topliss DJ, Stockigt JR, George PM, Barlow JW. Thyroxine binding by human transthyretin variants: mutations at position 119, but not 54, increase thyroxine binding affinity. J. Clin. Endocrinol. Metab. 78: 459-462, 1994.

72. Woeber KA, Ingbar SH. The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J. Clin. Invest. 47: 1710-1721, 1968.

73. Moses AC, Lawlor J, Haddow J, Jackson IMD. Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine-binding prealbumin. N. Engl. J. Med. 306: 966-969, 1982.

74. Steinrauf LK, Hamilton JA, Braden BC, Murrell JR, Benson MD. X-ray crystal structure of the Ala-109 -> Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia. J. Biol. Chem. 268: 2425-2430, 1993.

75. Alper CA, Robin NI, Refetoff S. Genetic polymorphism of Rhesus thyroxine-binding prealbumin: Evidence for tetrameric structure in primates. Proc. Natl. Acad. Sci. (USA) 63: 775-781, 1969.

76. Bernstein RS, Robbins J, Rall JE. Polymorphism of monkey thyroxine-binding prealbumin (TBPA): Mode of inheritance and hybridization. Endocrinol. 86: 383-390, 1970.

77. van Jaarsveld PP, Branch WT, Edelhoch H, Robbins J. Polymorphism of Rhesus monkey serum prealbumin. Molecular properties and binding of thyroxine and retinol-binding protein. J. Biol. Chem. 248: 4706-44712, 1973.

78. Henneman G, Krenning EP, Otten M, Docter R, Bos G, Visser TJ. Raised total thyroxine and free thyroxine index but normal free thyroxine. A serum abnormality due to inherited increased affinity of iodothyronines for serum binding protein. Lancet 1: 639-642, 1979.

79. Lee WNP, Golden MP, Van Herle AJ, Lippe BM, Kaplan SA. Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine. J. Clin. Endocrinol. Metab. 49: 292-299, 1979.

80. Ruiz M, Rajatanavin R, Young RA, Taylor C, Brown R, Braverman LE, Ingbar S. Familial dysalbuminemic hyperthyroxinemia: A syndrome that can be confused with thyrotoxicosis. N. Engl. J. Med. 306: 635-639, 1982.

81. DeCosimo DR, Fang SL, Braverman LE. Prevalence of familial dysalbuminemic hyperthyroxinemia in Hispanics. Ann. Intern. Med. 107: 780-781, 1987.

82. Jensen IW, Faber J. Familial dysalbuminaemic hyperthyroxinemia: a review. J. Royal Soc. Med. 81: 34-37, 1988.

83. Sapin R, Gasser F, Chambron J. Hyperthyroxinémie familiale avec dysalbuminémie: Dépistage sur 21 000 patients a l'occasion d'un bilan thyroïden. Pathol. Biol. (Paris.) 37: 785-789, 1989.

84. Arevalo G. Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing. Clin. Chem. 37: 1430-1431, 1991.

85. DeNayer P, Malvaux P. Hyperthyroxinemia associated with high thyroxine binding to albumin in euthyroid subjects. J. Endocrinol. Invest. 5: 383-386, 1982.

86. Mendel CM, Cavalieri RR. Thyroxine distribution and metabolism in familial dysalbuminemic hyperthyroxinemia. J. Clin. Endocrinol. Metab. 59: 499-504, 1984.

87. Fleming SJ, Applegate GF, Beardwell CG. Familial dysalbuminemic hyperthyroxinemia. Postgrad. Med. J. 63: 273-275, 1987.

88. Wood DF, Zalin AM, Ratcliffe WA, Sheppard MC. Elevation of free thyroxine measurement in patients with thyrotoxicosis. Quart. J. Med. 65: 863-870, 1987.

89. Croxson MS, Palmer BN, Holdaway IM, Frengley PA, Evans MC. Detection of familial dysalbuminaemic hyperthyroxinaemia. Br. Med. J. 290: 1099-1102, 1985.

90. Weiss RE, Angkeow P, Sunthornthepvarakul T, Marcus-Bagley D, Cox N, Alper CP, Refetoff S. Linkage of familial dysalbuminemic hyperthyroxinemia to the albumin gene in a large Amish family. J. Clin. Endocrinol. Metab. 80: 116-121, 1995.

91. Petersen CE, Ha C-E, Jameson DM, Bhagavan NV. Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. J. Biol. Chem. 271: 19110-19117, 1996.

92. Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S. A missense mutation in the albumin gene produces familial disalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem. Biophys. Res. Commun. 202: 781-787, 1994.

93. Langsteger W, Stockigt JR, Docter R, Költringer P, Lorenz O, Eber O. Familial disalbuminaemic hyperthyroxinaemia and inherited partial TBG deficiency: fist report. Clin. Endocrinol. 40: 751-758, 1994.

94. Petersen CE, Ha CE, Harohalli K, Park DS, Feix JB, Isozaki O, Bhagavan NV. Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype. Clin. Chem. 45: 1248-1254, 1999.

95. Petersen CE, Ha CE, Harohalli K, Park DS, Bhagavan NV. Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics. Chem. Biol. Interact. 124: 161-172, 2000.

96. Peters T, Jr. Serum albumin. Adv. Prot. Chem. 37: 161-245, 1985.

97. Sarcione EJ, Aungst CW. Bisalbuminemia associated with albumin thyroxine-binding defect. Clin. Chim. Acta 7: 297-298, 1962.

98. Tarnoky AL, Lestas AN. A new type of bisalbuminemia. Clin. Chim. Acta 9: 551-558, 1964.

99. Andreoli M, Robbins J. Serum proteins and thyroxine-protein interaction in early human fetuses. J. Clin. Invest. 41: 1070-1077, 1962.

100. Hollander CS, Bernstein G, Oppenheimer JH. Abnormalities of thyroxine binding in analbuminemia. J. Clin. Endocrinol. Metab. 28: 1064-1066, 1968.

101. Murata Y, Refetoff S, Sarne DH, Dick M, Watson F. Variant thyroxine-binding globulin in serum of Australian Aborigines: Its physical, chemical and biological properties. J. Endocrinol. Invest. 8: 225-232, 1985.

102. Refetoff S, Dumont JE, Vassart G. Thyroid disorders. In: The Metabolic and Molecular Basis of Inherited Disease.The Metabolic and Molecular Basis of Inherited Disease. (8 ed.), edited by C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, B. Childs andB. Vogeldstein. New York: MacGraw-Hill, 2000, p. 4029-4075.

103. Janssen OE, Bertenshaw R, Takeda K, Weiss R, Refetoff S. Molecular basis of inherited thyroxine-binding globulin defects. Trends Endocrinol. Metab. 3: 49-53, 1992.